Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study
Year: 2018
Type: article
Study design: Observational Study
Abstract: Background: Type 2 diabetes is related to an increased risk of dementia. Preclinical studies of dipeptidyl peptidase-IV inhibitors (DPP-4i) for dementia have yielded promising results. Therefore, we investigated the risk of dementia in elderly patients with type 2 diabetes on DPP-4is and sulfonylureas (SU). Methods: Using a claims database called the Korean National Health Insurance Service Senior cohort, new users of DPP-4is and SUs were matched by 1:1 propensity score matching using 49 confounding variables (7552 new DPP-4is users and 7552 new SU users were matched by 1:1 propensity score matching; average age 75.4; mean follow-up period: 1361.9 days). Survival analysis was performed to estimate the risk of dementia. Results: The risk of all-cause dementia was lower in the DPP-4i group compared to the SU group (hazard ratio (HR) 0.66; 95% confidence interval (CI) 0.56–0.78; p < 0.001). Particularly, DPP-4i use showed a significantly lower risk of Alzheimer’s disease (HR 0.64; 95% CI 0.52–0.79; p < 0.001) and a lower risk, albeit non-significant, of vascular dementia compared to SU use (HR 0.66; 95% CI 0.38–1.14; p = 0.139). Conclusion: Our findings suggest that DPP-4i use decreases the risk of dementia compared to SU use in elderly patients with type 2 diabetes in a real-world clinical setting.
Source: Journal of Clinical Medicine
DOI: 10.3390/jcm8010028
Authors: Young-Gun Kim(Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft), Ja Young Jeon(Writing – review & editing), Hae Jin Kim(Writing – review & editing), Dae Jung Kim(Writing – review & editing), Kwan-Woo Lee(Writing – review & editing), So Young Moon(Writing – review & editing), Seung Jin Han(Conceptualization, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review & editing)
Institutions: Ministry of Health and Welfare, Ajou University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,137
Award: G1337614278
OpenAlex ID: W2908077522
